Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Rapid Dose Therapeutics Corp C.DOSE

Alternate Symbol(s):  RDTCF

Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. It provides disruptive drug delivery technologies designed to improve patient outcomes. Its flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream... see more

CSE:DOSE - Post Discussion

Rapid Dose Therapeutics Corp > Sales increase
View:
Post by lscfa on Oct 28, 2021 10:05am

Sales increase

For the quarter ended August 31 2021, the Company recognized revenue of $324,640. Sales for the quarter ended August 31, 2021 resulted from shipments of cannabis infused strips produced for Aphria Inc. and Thrive Cannabis. The Company began producing strips for Aphria Inc. upon receipt of a Purchase order for 1,118,000 strips. Sales of other products are awaiting regulatory approvals in Canada, the United States and in the United Kingdom. These approvals remain in process as of October 27, 2021 reflecting the impact of COVID and delays experienced in regulatory processes in Canada and other jurisdictions.
Comment by frebeach1 on Oct 28, 2021 1:35pm
Where did you find this report?
Comment by lscfa on Nov 09, 2021 10:41pm
MD&A on sedar.com.    
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities